Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis
Wenfei Wei, Rafia S. Rasu, José J. Hernández‐Muñoz, Renee J. Flores, Nahid Rianon, Genesis A. Hernández-Vizcarrondo, Adam T. Brown
Topics & Concepts
MedicineRivaroxabanApixabanAtrial fibrillationWarfarinAspirinStroke (engine)Context (archaeology)AnticoagulantQuality-adjusted life yearInternal medicinePopulationCardiologyCost effectivenessPaleontologyEnvironmental healthMechanical engineeringBiologyRisk analysis (engineering)EngineeringAtrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementHeart Failure Treatment and Management